Olympus BPH

Hadera, Israel Founded: 2007 • Age: 19 yrs Acquired By Olympus
General medical services are provided at a standalone clinic.

About Olympus BPH

Olympus BPH is a Healthcare company based in Hadera (Israel) founded in 2007, and was acquired by Olympus in February 2021. It operates as a general medical services are provided at a standalone clinic. It operates on a HealthTech model. Olympus BPH offers products and services including iTind Procedure. Its focus areas include Medical Devices and Urological Devices. Its legal entity is Olympus Corporation of the Americas.

Company details

Olympus BPH, under Olympus Corporation of the Americas, is dedicated to providing innovative solutions for benign prostatic hyperplasia (BPH) through the iTind procedure. This minimally invasive treatment is designed to address urinary symptoms caused by an enlarged prostate, offering rapid symptom relief while preserving sexual and urinary functions. The solution targets men aged 50 and older, serving the healthcare sector with a focus on urology.

  • Headquarters Hadera, Israel
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website itind.com
  • Social LinkedIn
  • Acquired by Olympus (Feb 2021)
  • Legal Name Olympus Corporation Of The Americas
Key Metrics
  • Latest Funding Round
    $20M (USD), Unspecified

    Nov 2018

  • Investors
    Olympus

    & 1 more

  • Acquired by
    Olympus

    (Feb 2021)

Products & Services of Olympus BPH

Olympus BPH offers a comprehensive portfolio of products and services, including iTind Procedure.

iTind Procedure
Medical Device

A minimally invasive treatment for enlarged prostate issues.

Funding Insights of Olympus BPH

  • Total Rounds 2
  • Last Round Unspecified β€” $20M
  • Investors Count 2

All 2 funding rounds of Olympus BPH with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2018$20MUnspecified–Olympus
–
Jul 2016–Series A–Laborie Medical
–
Valuation history

2 investors in total: 2 institutional.

Investors in Olympus BPH

Olympus BPH has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Olympus and Laborie Medical.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Manufacturer of imaging and surgical products
1919olympus-global.comTokyo, Japan
Medical products for female lower urinary tract dysfunctions are provided.
1967laborie.comMississauga, Canada
Premium access

Investor details for Olympus BPH

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Olympus BPH

4 dated milestones of Olympus BPH across 14 years, from founding to its latest funding, stage changes and deals.

  1. Founded Olympus BPH is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Unspecified, of $20.0M.
  4. Exit Acquired by Olympus.

Web traffic of Olympus BPH

The website of Olympus BPH (itind.com) receives about 1.9K visits a month.

  • Monthly visits
    1.9K

    ▲ 10.9% vs previous month

Similar websites

Websites whose visitors overlap most with Olympus BPH. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
austinurologyinstitute.com
austinurologyinstitute.com
100%
–#1,874,783–

Top companies in Hospitals & Clinical Care

10 companies that operate in the same segment as Olympus BPH (Hospitals & Clinical Care), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Maternity, childcare, and fertility services are delivered via hospital chains.
2007Bengaluru, Karnataka, IndiaUSD 204.87 MUSD 140.46 M4,459
Chain of oncology hospitals
1989Bengaluru, Karnataka, IndiaUSD 36.59 MUSD 270.51 M8,400
Chain of multi-super specialty healthcare hospitals
2004Gurugram, Haryana, IndiaUSD 104.7 MUSD 461.72 M12,240
Multispeciality secondary and tertiary care is provided by hospital chains.
1999Secunderabad, Telangana, IndiaUSD 62.46 MUSD 416.2 M6,490
Multispecialty hospitals are operated as a chain in India.
2001Delhi, Delhi, India–USD 889.96 M26,830
Multi-specialty hospitals and surgery centers are operated nationwide.
1968Nashville, Tennessee, United StatesUSD 97.27 MUSD 75.6 B316,000
Standalone veterinary clinics are operated for pet care services.
2017New York, New York, United StatesUSD 98.5 M––
Healthcare services, research, education, and community support are provided.
1942United States–––
Provider of tech-heavy clinics for multiple healthcare solutions for patients
2017Brooklyn, New York, United StatesUSD 1.02 B–785
Multispecialty hospitals are operated as a chain in India.
1991Bengaluru, Karnataka, IndiaUSD 645.32 MUSD 1.1 B–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Olympus BPH

Olympus BPH was founded in 2007 and raised its 1st funding round 9 years after it was founded.

Olympus BPH is headquartered in Hadera, Israel. It is registered at Hadera, Central District, Israel.

Olympus BPH, under Olympus Corporation of the Americas, is dedicated to providing innovative solutions for benign prostatic hyperplasia (BPH) through the iTind procedure. This minimally invasive treatment is designed to address urinary symptoms caused by an enlarged prostate, offering rapid symptom relief while preserving sexual and urinary functions. The solution targets men aged 50 and older, serving the healthcare sector with a focus on urology.

Olympus BPH offers iTind Procedure.

Olympus BPH has 2 investors. Key investors include Olympus, and Laborie Medical.

Olympus BPH operates through Olympus Corporation Of The Americas.

Yes. Olympus BPH was acquired by Olympus in February 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available